GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
Read More...
Focus:
-
![]()
New Data Suggest HCV Remains a Problem in the US
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in...
Read More...
-
![]()
Industry Viewpoints: The Challenges of Clinical Data Management
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising...
Read More...
-
![]()
How Can Blockchain Disrupt the Pharma Industry?
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Read More...
-
![]()
Expert Insights: Moderna Therapeutics Barrels Ahead Towards Historic IPO
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young...
Read More...
-
![]()
Industry Viewpoints: Leveraging eSource in Data Management
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management...
Read More...
-
![]()
Perfect Communication? That’s an Oxymoron!
Audrey Hill, Senior Director, Data Management, Advaxis, Inc., explains the keys to clear communication in...
Read More...
-
![]()
Enriched Evidence Generation: Linking Clinical Data, Registries and Patient-Reported Outcomes to Health Care Utilization
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims...
Read More...
-
![]()
Expert Insights: Another Failure for BACE1 Drugs Raises Questions about Alzheimer’s Disease Treatments
Alessio Brunello, MSc, Neurology & Ophthalmology Analyst, GlobalData, explores the implications of Janssen’s decision to...
Read More...
